Israeli Minister Signs A Decree Dividing Authorities In The West Bank

AJN Agency.- More and more patients are prescribed cannabis to relieve chronic pain and other problems. And more and more people are consuming weed as a “food” recreationally instead of smoking it.

Both the groups face the same problem. It is hard for the human body to absorb cannabis because it is not water soluble.

Israeli researchers have found a solution. They trick the body into thinking that cannabis is food by binding to proteins.

Thus, instead of waiting for two hours, people who consume cannabis will feel the effects in just 15 minutes.

This will make a world of difference to both those looking to get rid of a painful ailment and those who just want to get high fast (where legal).

“What we’ve created is a natural protein carrier that ‘ubers’ cannabis through its system,” says Rafi Cohen, director of business at Day Three Labs (DTL), the company that developed the technology.

“So it naturally bypasses your digestive system because your body thinks it’s absorbing and digesting the protein.”

Inspired by the way we digest food, she says she is the first woman in the world to successfully bind proteins with hemp.

The patented technology – called Unloc because it unlocks the body’s ability to digest cannabis – took six years to develop at the company’s pharmaceutical research laboratory in Yeruham, southern Israel (the company is based in Denver, Colorado, USA located where cannabis is legal).

It turns whey or chickpea proteins into tiny nanosponges that bind to THC (the psychoactive ingredient) or other cannabinoids (compounds in cannabis that affect our bodies and minds).

As a result, they become water soluble and much easier for the body to digest.

Day Three Labs, which takes its name from the creation of plants on the third day (Genesis 1.11), claims that its innovative technology is already being used for recreational products.

Its medical use for various chronic diseases will take longer due to the R&D required to develop specific formulations for each disease.

The company can make enough protein for use in thousands of products every day. Manufacturers use proteins for any number of food types, such as candy, tablets and drinks.

There are 700 varieties of cannabis, and each one produces slightly different effects, such as increasing energy, inducing a state of euphoria, or relieving symptoms of neurological conditions such as epilepsy.

Regular foods are unable to produce these effects and typically cause users to experience “couch lock,” or a state of intense sedation.

But people who consume foods infused with DTL’s Unloc technology can actually experience the effects of the particular strain they’ve ingested, the company claims.

“For a cannabis user, this can be very important if they want to have a particular experience in the morning or afternoon, or if they are using a specific strain for shoulder pain, Parkinson’s, or nausea,” Cohen says. .

“We hand over our protein-based ingredients to a cannabis producer, and they do what they want with it.”

DTL’s proteins are already being used by several US companies to make gummies in the states of Colorado and California, where cannabis is legal.

And in North Carolina, a company is using them to develop tongue strips, disintegrating tablets, gummies, sprays and more.

Additionally, DTL works to find the right cannabinoid formula for patients suffering from various chronic disorders.

Its first drug development program targets people who suffer from insomnia and other sleep disorders and after three years of R&D, products infused with protein and cannabinoid formulas are about to hit US shelves.

Dr. Shimon Lecht, Chief Innovation Officer, says: “In our view, we see cannabis as a rich source of active ingredients that we need to understand and develop into real therapies.

“Our goal as drug developers is not only to help people get as high as possible, but to actually help them.”

More recently, DTL has initiated a drug development program to find precise formulations for Parkinson’s disease.

“For the past 30 years, nothing has really been done to help them,” he says.

Cohen says, “We have been able to isolate different cannabinoids and create an appropriate formulation tailored to Parkinson’s, or sleep disorders, or other medical needs, and combine it with our delivery system, which is our technological innovation. ”

“These patients will not need to smoke and stay at home as they have stones all day long. And it also has no side effects as it is a completely natural medicine.

Day Three Labs is also associated with CannaGev, a government-backed technology incubator to support entrepreneurs and startups in the south of the country. They employ highly educated people in the Negev to help them with their research.

Source: NoCamels.com

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *